• to decreased the risk of critical cardiovascular (heart and blood vessel) problems in Older people with sort 2 diabetes and heart problemsCalifornia biotech behemoth Amgen ditched plans for an experimental weight loss tablet in May perhaps but remains to be hoping for the slice of the market with MariTide, a regular injection that is certainly